Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
| 22.57 Delayed Data As of Jan 24 |  -0.24 / -1.05%Today’s Change | 14.33 Today|||52-Week Range 28.81 | -10.04% Year-to-Date |
Latest CRNX News | Press Releases
No recent news for Crinetics Pharmaceuticals Inc.
Today’s Trading
| Previous close | 22.81 |
| Today’s open | 23.75 |
| Day’s range | 22.22 - 23.75 |
| Volume | 33,342 |
| Average volume (3 months) | 59,261 |
| Market cap | $546.7M |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | -483.08% |
| Earnings growth (this year) | +2.99% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IPHAInnate Pharma SA | -0.40 | -5.21% |
| ASMBAssembly Biosciences... | -0.31 | -1.82% |
| KURAKura Oncology Inc | -0.47 | -3.83% |
| MGNXMacroGenics Inc | -0.60 | -5.26% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
